World Lifestyler
  • Art & Culture
    • Architecture
    • Art & Exhibitions
    • Books
    • Design
    • Film & Music
  • Competitions
    • Dining Experiences
    • Hotel Stays
    • Luxury Experiences
    • Product Giveaways
    • Reader Exclusives
    • Travel Giveaways
  • Food & Drink
    • Chefs
    • Coffee Culture
    • Food Destinations
    • Recipes
    • Restaurants
    • Wine & Spirits
  • Lifestyle
    • Design
    • Fashion
    • Health & Wellbeing
    • Homes & Property
    • Love & Romance
  • People
    • Creatives
    • Entrepreneurs
    • Icons
    • Interviews
    • Profiles
    • Rising Talent
  • Travel
    • Adventure & Experience Travel
    • City Guides
    • Destinations
    • Hotels
    • Secret Spots
    • Travel Trends
  • Art & Culture
    • Architecture
    • Art & Exhibitions
    • Books
    • Design
    • Film & Music
  • Competitions
    • Dining Experiences
    • Hotel Stays
    • Luxury Experiences
    • Product Giveaways
    • Reader Exclusives
    • Travel Giveaways
  • Food & Drink
    • Chefs
    • Coffee Culture
    • Food Destinations
    • Recipes
    • Restaurants
    • Wine & Spirits
  • Lifestyle
    • Design
    • Fashion
    • Health & Wellbeing
    • Homes & Property
    • Love & Romance
  • People
    • Creatives
    • Entrepreneurs
    • Icons
    • Interviews
    • Profiles
    • Rising Talent
  • Travel
    • Adventure & Experience Travel
    • City Guides
    • Destinations
    • Hotels
    • Secret Spots
    • Travel Trends
No Result
View All Result
WORLD LIFESTYLER
No Result
View All Result
Home Press Releases Press Releases - Lifestyle

From Pakistan to Shanghai: A CAR-T Journey Fighting Relapsed Lymphoma

Cision PR Newswire by Cision PR Newswire
May 25, 2026
in Press Releases - Lifestyle
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

SHANGHAI, May 25, 2026 /PRNewswire/ — A 36-year-old Pakistani patient has achieved encouraging early recovery after receiving personalized CAR-T immunotherapy at Jiahui International Cancer Center in Shanghai, following exhausting standard treatments for aggressive recurrent blood cancer.

Muhammad, a hospital staff member from Quetta, Pakistan, suffered from diffuse large B-cell lymphoma (DLBCL). After multiple chemotherapy courses and a failed bone marrow transplant, his disease progressed to Stage IVB by early 2026, with widespread metastasis in the lungs, pleura and bones, accompanied by severe, intractable pain. Local doctors confirmed no further effective conventional treatments and recommended overseas advanced therapy, with his overseas treatment application officially approved by Pakistan’s national medical board.

After evaluating medical institutions across multiple countries, Muhammad chose Jiahui for its efficient consultation services and thoughtful patient guidance throughout the pre-treatment process.

Given Muhammad’s complex condition along with extensive tumor burden, Dr. Hao Siguo, the Chief Hematology Consultant, developed a personalized CAR-T therapy regimen for him following remote consultation. To reduce tumor volume ahead of cell infusion, he designed a bridging therapy combining chemotherapy and local radiotherapy. The strategy later successfully lowered infusion-associated risks and improved overall treatment efficacy.

With stable vital organ function, the multidisciplinary team proceeded with the customized therapy. After the patient underwent lymphocyte collection, the first step of the CAR-T process, and preparatory therapies to optimize his physical condition for safe cell infusion, Muhammad received his personalized CAR-T cell infusion on April 23, 2026. During inpatient observation, he only experienced mild, manageable cytokine release syndrome with no severe neurotoxicity. Significant clinical improvements emerged rapidly: his severe cancer pain was greatly relieved, and reliance on opioid medications was drastically reduced. Pre-discharge tests showed shrinking lesions and normalized key laboratory indicators.

Throughout his treatment, Jiahui’s international care team provided full support including professional translation services and halal catering to accommodate his cultural and religious needs.

He spoke positively about his experience in China and the support he received, saying, “Chinese people are very cooperative. The doctors, nurses, and staff were very supportive.” Discharged on May 7, 2026, Muhammad will complete regular follow-up imaging and monitoring back in Pakistan.

The case highlights Jiahui International Cancer Center’s expertise in refractory lymphoma CAR-T therapy and its capacity to deliver standardized, patient-centered cross-border medical services for global patients with complex oncological conditions.

Read more: https://jiahui.com/en/news/211

Contact the International Office
Email: internationaloffice@jiahui.com
WhatsApp: +852 4619 1904

Cision View original content:https://www.prnewswire.co.uk/news-releases/from-pakistan-to-shanghai-a-car-t-journey-fighting-relapsed-lymphoma-302780887.html

Cision PR Newswire

Cision PR Newswire

Related Posts

The One Where SHEGLAM Meets FRIENDS

October 26, 2026

Rapidus and HCLTech announce partnership for next-generation semiconductor technologies

October 26, 2026

Parloa’s Agent Management Platform now sold as an SAP Solution Extension for agentic customer interactions

October 26, 2026

Temu Partners with Spain’s Recyclia to Support Seller Extended Producer Responsibility

October 26, 2026

SUNON Brings AI, Nature and Human-Centered Design to ORGATEC 2026

October 26, 2026

Innovent Announces NMPA Acceptance of a New Indication Application of Sintilimab for the Treatment of Advanced Melanoma

October 26, 2026

Popular News

  • Thunes and PayerMax Deepen Strategic Collaboration to Enhance Global Payout Capabilities

    0 shares
    Share 0 Tweet 0
  • Linux Foundation Announces the Open Financial Trust Alliance to Strengthen Coordinated Protection Against Fraud, Scams and Financial Crime

    0 shares
    Share 0 Tweet 0
  • DEFSEC TECHNOLOGIES INC. COMMENTS ON NASDAQ NOTIFICATION REGARDING BID PRICE DEFICIENCY AND PROACTIVE STEPS ALREADY TAKEN TO REGAIN AND MAINTAIN COMPLIANCE

    0 shares
    Share 0 Tweet 0
  • PingPong Hits $300 Billion in Annualised Transaction Volume as APAC Surges, and Launches “Currentz” for Banks

    0 shares
    Share 0 Tweet 0
  • Charter Announces Pricing Terms of Tender Offers for Eight Series of Notes

    0 shares
    Share 0 Tweet 0

About & Contact

  • About Us
  • Branding Style Guide
  • Contact Us
  • Help Centre
  • Media Kit
  • Site Map

Explore Content

  • Events
  • Newsletter
  • Press Releases
  • Topics

Legal & Privacy

  • Advertiser & Partner Policy
  • Communications & Newsletter Policy
  • Contributor Agreement
  • Copyright Policy
  • Privacy Policy
  • Prohibited Content Policy
  • Terms of Service

Tiny Media Brands

  • Silicon Valleys Journal
  • The AI Journal
  • The City Banker
  • The Wall Street Banker
  • World Lifestyler

© 2025 World Lifestyler

No Result
View All Result
  • Home

© 2025 World Lifestyler